Used in cancer research to selectively inhibit CYP1B1, an enzyme overexpressed in various tumor cells. This inhibition helps block the metabolism of procarcinogens and the inactivation of certain anticancer drugs, potentially enhancing chemotherapy efficacy. Also employed as a tool compound to study the role of CYP1B1 in drug resistance and tumor progression. Shows promise in improving the effectiveness of existing cancer treatments by modulating metabolic pathways in malignant cells.